BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 37365560)

  • 1. SLC25A32 promotes malignant progression of glioblastoma by activating PI3K-AKT signaling pathway.
    Xue Z; Wang J; Wang Z; Liu J; Zhao J; Liu X; Zhang Y; Liu G; Zhao Z; Li W; Zhang Q; Li X; Huang B; Wang X
    BMC Cancer; 2023 Jun; 23(1):589. PubMed ID: 37365560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABCF1/CXCL12/CXCR4 Enhances Glioblastoma Cell Proliferation, Migration, and Invasion by Activating the PI3K/AKT Signal Pathway.
    Yin X; Xia K; Peng S; Tan B; Huang Y; Wang M; He M
    Dev Neurosci; 2024; 46(3):210-220. PubMed ID: 37757768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HNF1A induces glioblastoma by upregulating EPS8 and activating PI3K/AKT signaling pathway.
    Yang G; Su F; Han BX; Su HX; Guo CH; Yu SH; Guan QL; Hou XM
    Biochem Pharmacol; 2024 May; 223():116133. PubMed ID: 38494066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Columbianadin suppresses glioblastoma progression by inhibiting the PI3K-Akt signaling pathway.
    Zhang W; Dong J; Xu J; Qian Y; Chen D; Fan Z; Yang H; Xiang J; Xue X; Luo X; Jiang Y; Wang Y; Huang Z
    Biochem Pharmacol; 2024 May; 223():116112. PubMed ID: 38458331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WTAP regulates the production of reactive oxygen species, promotes malignant progression, and is closely related to the tumor microenvironment in glioblastoma.
    Ji Q; Guo Y; Li Z; Zhang X
    Aging (Albany NY); 2024 Mar; 16(6):5601-5617. PubMed ID: 38535989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endosome associated trafficking regulator 1 promotes tumor growth and invasion of glioblastoma multiforme via inhibiting TNF signaling pathway.
    Zhang Q; Dai Z; Chen Y; Li Q; Guo Y; Zhu Z; Tu M; Cai L; Lu X
    J Neurooncol; 2024 Jan; 166(1):113-127. PubMed ID: 38191954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD97 is associated with mitogenic pathway activation, metabolic reprogramming, and immune microenvironment changes in glioblastoma.
    Safaee MM; Wang EJ; Jain S; Chen JS; Gill S; Zheng AC; Garcia JH; Beniwal AS; Tran Y; Nguyen AT; Trieu M; Leung K; Wells J; Maclean JM; Wycoff K; Aghi MK
    Sci Rep; 2022 Jan; 12(1):1464. PubMed ID: 35087132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stabilization of KPNB1 by deubiquitinase USP7 promotes glioblastoma progression through the YBX1-NLGN3 axis.
    Li J; Zhang B; Feng Z; An D; Zhou Z; Wan C; Hu Y; Sun Y; Wang Y; Liu X; Wei W; Yang X; Meng J; Che M; Sheng Y; Wu B; Wen L; Huang F; Li Y; Yang K
    J Exp Clin Cancer Res; 2024 Jan; 43(1):28. PubMed ID: 38254206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unraveling the intricacies of glioblastoma progression and recurrence: insights into the role of NFYB and oxidative phosphorylation at the single-cell level.
    Liu P; Xing N; Xiahou Z; Yan J; Lin Z; Zhang J
    Front Immunol; 2024; 15():1368685. PubMed ID: 38510250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The embryonic stem cell microenvironment inhibits mouse glioma cell proliferation by regulating the PI3K/AKT pathway.
    He X; Liu J; Wang X; Liu T; Yang L; Li C; Wang C; Liu Y; Sang X; Wang Z; Lu X
    Transl Cancer Res; 2021 Jan; 10(1):487-498. PubMed ID: 35116278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ZBTB20 suppresses tumor growth in glioblastoma through activating the TET1/FAS/caspase‑3 pathway.
    Duan P; Li B; Zhou Y; Cao H; Chen S; Xing Y
    Oncol Lett; 2024 Aug; 28(2):358. PubMed ID: 38881713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Panoramic RNA expression of fibroblast growth factors in human glioblastoma tissues and the impact on the survival of patients.
    Zhao K; Xu J; Zhao B
    Oncol Lett; 2024 Jul; 28(1):317. PubMed ID: 38807663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of SLC27A2 predicts unfavorable prognosis and promotes inhibitory immune infiltration in acute lymphoblastic leukemia.
    Lu L; Li J; Zheng Y; Luo L; Huang Y; Hu J; Chen Y
    Transl Oncol; 2024 Jul; 45():101952. PubMed ID: 38640787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Status and Future Perspective in Glioma Invasion Research.
    Ohnishi T
    Brain Sci; 2024 Mar; 14(4):. PubMed ID: 38671961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cells, as glioma exosomal immunosuppressive signal multipliers, enhance MDSCs immunosuppressive activity through the miR-21/SP1/DNMT1 positive feedback loop.
    Qiu W; Guo Q; Guo X; Wang C; Li B; Qi Y; Wang S; Zhao R; Han X; Du H; Zhao S; Pan Z; Fan Y; Wang Q; Gao Z; Li G; Xue H
    J Nanobiotechnology; 2023 Jul; 21(1):233. PubMed ID: 37481646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiomics data analyses to identify SLC25A17 as a novel biomarker to predict the prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    Shi Y; Huang J; Hu Y; Shen Y
    BMC Bioinformatics; 2023 Jun; 24(1):269. PubMed ID: 37386359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ECM Composition Differentially Regulates Intracellular and Extracellular pH in Normal and Cancer Pancreatic Duct Epithelial Cells.
    Di Molfetta D; Cannone S; Greco MR; Caroppo R; Piccapane F; Carvalho TMA; Altamura C; Saltarella I; Tavares Valente D; Desaphy JF; Reshkin SJ; Cardone RA
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic inactivation of the Carnitine/Acetyl-Carnitine mitochondrial carrier of Yarrowia lipolytica leads to enhanced odd-chain fatty acid production.
    Messina E; de Souza CP; Cappella C; Barile SN; Scarcia P; Pisano I; Palmieri L; Nicaud JM; Agrimi G
    Microb Cell Fact; 2023 Jul; 22(1):128. PubMed ID: 37443049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted cross-linker delivery for the in situ mapping of protein conformations and interactions in mitochondria.
    Chen Y; Zhou W; Xia Y; Zhang W; Zhao Q; Li X; Gao H; Liang Z; Ma G; Yang K; Zhang L; Zhang Y
    Nat Commun; 2023 Jun; 14(1):3882. PubMed ID: 37391416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological targeting of one‑carbon metabolism as a novel therapeutic strategy for glioblastoma.
    Sun Y; Mu G; Xue Z; Li X; Lin X; Han M
    J Transl Med; 2023 Jun; 21(1):424. PubMed ID: 37386497
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.